Shares of cryptocurrency exchange Coinbase (NASDAQ:COIN) fell 8.2% in the morning session after stocks tied to the crypto market fell, mirroring the weakness in digital assets. Bitcoin, the largest cryptocurrency by market cap, dropped to $87,000, a 20% decline from its all-time high of $109,114 on January 20, 2025. Historically, when Bitcoin stumbles, the broader crypto market takes a harder hit, and this time is no exception.
Sempra Stock Leads S&P 500 Decliners on Lowered Profit Forecast
Sempra stock was the biggest decliner in the S&P 500 intraday Tuesday after the energy company's fourth-quarter results and profit projections fell short of estimates.
Artivion (AORT) Stock Trades Down, Here Is Why
Shares of medical device company Artivion (NYSE:AORT) fell 11.2% in the morning session after the company reported weak fourth-quarter 2024 results, as both revenue and EPS missed Wall Street's expectations. While revenue did grow 4% year-on-year, it still fell short, partly due to the late-November cybersecurity incident that disrupted operations.
Why Is Integra LifeSciences (IART) Stock Rocketing Higher Today
Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 13.6% in the afternoon session after the company reported strong fourth quarter 2024 results that beat analysts' EPS and EBITDA expectations.
Krispy Kreme (DNUT) Stock Trades Down, Here Is Why
Shares of doughnut chain Krispy Kreme (NASDAQ:DNUT) fell 26.1% in the pre-market session after the company reported disappointing Q4 2024 results as it missed across all key metrics, including sales, operating profits, and earnings. Revenue fell 10.4% year on year, reflecting a decline in U.S. sales due to the Insomnia Cookies divestiture and the impact of a cybersecurity incident that cost an estimated $11 million in lost revenue.
Why AdaptHealth (AHCO) Stock Is Trading Up Today
Shares of healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) jumped 28% in the morning session after the company reported strong fourth-quarter 2024 results with revenue surpassing forecasts and driving EPS well above Wall Street estimates. While full-year revenue guidance came in slightly below expectations, full-year EBITDA guidance exceeded projections. Overall, this quarter had some key positives.
Fed's Barkin prefers to 'wait and see' on rates amid Trump policy uncertainty
Richmond Fed president Tom Barkin said Tuesday that he wants to keep interest rates "modestly restrictive" until he gains more confidence inflation is returning to the central bank's 2% goal, warning about lessons learned from the 1970s.
Why Is Portillo's (PTLO) Stock Soaring Today
Shares of casual restaurant chain Portillo’s (NASDAQ:PTLO) jumped 9.8% in the morning session after the company reported strong fourth-quarter 2024 results, significantly exceeding analysts' EPS expectations despite revenue coming in line with forecasts. EBITDA also outperformed Wall Street's estimates, showing that profitability was better than expected. Overall, we think this was a solid quarter with some key areas of upside.
Why UFP Technologies (UFPT) Stock Is Trading Up Today
Shares of medical products company UFP Technologies (NASDAQ:UFPT) jumped 9.9% in the afternoon session after the company delivered an encouraging quarter, surpassing analysts' expectations for revenue, EPS, and EBITDA. Sales surged 41.9% y/y, driven by strong performance in the MedTech segment, which grew 48.6%, while other markets saw a modest decline. Profitability improved as gross margins expanded to 29.2%, helping the company deliver the earnings beat.
Primoris (PRIM) Stock Trades Up, Here Is Why
Shares of infrastructure construction company Primoris (NYSE:PRIM) jumped 10.5% in the pre-market session after the company reported impressive fourth-quarter results that exceeded analysts' backlog, revenue, EPS, and EBITDA estimates. Revenue grew by 14.9% y/y, driven primarily by strong performance in the Energy and Utilities segments. Operating income saw a modest increase, as gross margins in the utilities segment improved significantly. Looking ahead, full-year EPS and EBITDA guidance excee